Is Moderna (MRNA) Pricing Reflecting Potential After Sharp Multi‑Year Share Price Pullback?

If you are wondering whether Moderna's current share price reflects its true potential, or if the market is still anchored to its pandemic story, this article will help you unpack what the numbers may ...
Morningstar

Moderna: Fair Value Lowered on ‘Hostile’ FDA Environment

Since Robert F. Kennedy Jr. was confirmed as secretary of the Department of Health and Human Services on Feb. 13, recent disruptions at the Food and Drug Administration include a return-to-office ...

FDA Flu Setback Tests Moderna Valuation And Future mRNA Vaccine Pipeline

U.S. FDA issues a Refusal to File for Moderna's mRNA flu vaccine BLA, citing concerns with the trial comparator rather than safety or efficacy. Moderna, ticker NasdaqGS:MRNA, says the trial design and ...
Seeking Alpha

Moderna: Betting On Bird Flu Rally Is A Poor Strategy For A Value Investor

Moderna's stock price is rising on fears of a new infectious disease outbreak, and this is reminiscent of the company's pandemic gains. Moderna and Pfizer have been in talks with the Department of ...
Morningstar

After Earnings and a Big Selloff, Is Moderna Stock a Buy?

With a 5-star rating, Moderna stock is significantly undervalued compared with our fair value estimate. We’re maintaining our $227 fair value estimate for no-moat firm Moderna despite disappointing ...
The Business Journals

Moderna loses $5B in market value after new data on RSV vaccine

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Months before Moderna Inc. plans ...
Seeking Alpha

Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today?

Five years ago, Moderna, Inc. (MRNA) and Novavax, Inc. (NVAX) were two of the most talked about stocks across platforms like Seeking Alpha, social media, and likely in the national press of most ...
Nasdaq

Moderna Offers Deep Value as Drug Pipeline Flows Fast

It’s crazy the way Wall Street can love a company but then abandon it soon afterwards. Massachusetts-based Moderna (NASDAQ:MRNA) was the darling of the market during the initial onset of covid-19 in ...
Stars and Stripes

Moderna shaves off $7 billion in value after Pfizer warning

The pandemic officially ended months ago, allowing a weary public to get back to normal living. That was great news for large swaths of the economy. But not all of it. Moderna Inc., which shot to fame ...
Investing

Moderna Stock Rallies as Oncology Results Improve the Platform’s Value Case

Moderna, Inc. shares surged 7.19% to $46.09 as of 10:41:50 AM EST on January 21, 2026, following a major announcement with partner Merck regarding their experimental personalized cancer vaccine. The ...
AOL

Moderna Chairman Refuses To Share Vaccine Formula — Will Pfizer’s Popularity Hurt Its Stock Value?

Moderna recently ruffled feathers by announcing it has no plans to share the recipe for its COVID-19 vaccine, as they believe that scaling up the company’s own production is the best way to increase ...